BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 24513420)

  • 1. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
    Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
    Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new ballgame: comprehensive medication review.
    McSpadden C
    Consult Pharm; 2014 Feb; 29(2):76-8, 80-1, 83. PubMed ID: 24513418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjoint analysis of patient preferences on Medicare medication therapy management.
    Hong SH; Liu J; Wang J; Brown L; White-Means S
    J Am Pharm Assoc (2003); 2011; 51(3):378-87. PubMed ID: 21555290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
    de Oliveira DR; Brummel AR; Miller DB
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
    Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
    J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
    J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
    Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
    J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pharmacists' barriers to the implementation of medication therapy management services.
    Lounsbery JL; Green CG; Bennett MS; Pedersen CA
    J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid services.
    Shoemaker SJ; Hassol A
    J Am Pharm Assoc (2003); 2011; 51(4):520-6. PubMed ID: 21752775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contingent valuation and pharmacists' acceptable levels of compensation for medication therapy management services.
    Wang J; Hong SH
    Res Social Adm Pharm; 2015; 11(3):e121-32. PubMed ID: 22436583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries.
    Welch EK; Delate T; Chester EA; Stubbings T
    Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
    MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
    J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting demand among older adults for medication therapy management services.
    Brooks JM; Unni EJ; Klepser DG; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2008 Dec; 4(4):309-19. PubMed ID: 19064238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of medication therapy management services in assisted living facilities in rural Minnesota.
    Scott DM; Dewey MW; Johnson TA; Kessler ML; Friesner DL
    Consult Pharm; 2010 May; 25(5):305-19. PubMed ID: 20497929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.